Pulmonary Blastoma with Renal Metastasis Responds to Sorafenib

Slides:



Advertisements
Similar presentations
Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Advertisements

A Hole in the Heart Journal of Thoracic Oncology
Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer  Anne S. Tsao, MD, Xi Ming Tang, MD, PhD, Bradley Sabloff, MD,
Wei-Wen Yu, Chiau-Sheng Jang  Dermatologica Sinica 
Akos Varga-Szemes, MD, PhD, U. Joseph Schoepf, MD, Laura S
Invasive Inflammatory Myofibroblastic Tumor of the Lung
Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A
Y-L Chang, MD, C-T Wu, MD, Y-C Lee, MD, PhD 
The Case of the Missed Chest Radiograph: Bilateral Mammary Gland Metastases Mimicking Multifocal Primary Breast Cancer as the Initial Manifestation of.
Sclerosing Pneumocytoma with Lymph Node Metastasis
Differential Diagnosis of Primary Versus Metastatic Pulmonary Adenocarcinomas Using Gene Mutation Analyses: A Case Report  Yoshimasa Nakazato, MD, Ryota.
David T. Cooke, MD, Dennis J. Zheng, Karen A. Peterson, NP, Royce F
Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer: A Brief Report  Tsu-Hui Shiao, MD, Yih-Leong Chang, MD, Chong-Jen Yu, MD, PhD, Yeun-Chung.
KRAS Mutation Analysis Helps to Differentiate Between Pulmonary Metastasis from Colon Adenocarcinoma In Situ and Primary Lung Adenocarcinoma  Taylor M.
Treatment of Pulmonary Epithelioid Hemangioendothelioma with Bevacizumab  Young Hak Kim, MD, Michiaki Mishima, MD, PhD, Aya Miyagawa-Hayashino, MD, PhD 
Electronic Updates for JTO Readers
Primary Pulmonary Choriocarcinoma Presenting with a Hemothorax
Miliary Mesothelioma: A New Clinical and Radiological Presentation in Mesothelioma Patients with Prolonged Survival After Trimodality Therapy  Lesek Purek,
Muhammad Umair Khawar, MD, Bhaskar Bhardwaj, MD, Himanshu Bhardwaj, MD 
Patrick H. Archie, MD, Mary Beth Beasley, MD, Helen J. Ross, MD 
An Unusual Presentation of Malignant Pleural Mesothelioma
Difference in Clonality as a Tool for Differential Diagnosis of Primary Versus Secondary Lung Neoplasms  Giovanni Leuzzi, MD, Alfredo Cesario, MD, Maria.
Germline and Somatic DICER1 Mutations in a Well-Differentiated Fetal Adenocarcinoma of the Lung  Leanne de Kock, B.Tech, Ismaël Bah, MD, Yingchen Wu,
Coexistence of the BRAF Mutation and EGFR Exon 20 Insertion in a Patient with Lung Adenocarcinoma  Lih-Chyun Chang, MD, Kuan-Yu Chen, MD, PhD, Jin-Yuan.
Complete Radiological Response of Metastatic Anaplastic Lymphoma Kinase-Positive Signet Ring Lung Adenocarcinoma to Systemic Chemotherapy  Grzegorz Korpanty,
Hepatoid Carcinoma of the Lung with Anaplastic Lymphoma Kinase Gene Rearrangement  Sean Khozin, MD, Mark J. Roth, MD, Arun Rajan, MD, Karen Smith, MD,
Why Do Pathological Stage IA Lung Adenocarcinomas Vary from Prognosis
Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence?  Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer  Anne S. Tsao, MD, Xi Ming Tang, MD, PhD, Bradley Sabloff, MD,
Surgical Treatment of a Giant Symptomatic Cardiac Lipoma
Multiple Pulmonary Chondroid Hamartoma
Lung Metastases from Esophageal Granular Cell Tumor: An Undoubted Criterion for Malignancy  Isidro Machado, MD, PhD, Julia Cruz, MD, PhD, Estanislao Arana,
Adnan M. Al-Ayoubi, MD, Jonathan S. Ralston, MD, S
Mark L. Kayton, MD, Mai He, MD, PhD, Maureen F. Zakowski, MD, Andre L
Ritbune Prakobkit, MD, William Churk-Nam Auyeung, MD 
Complete Resection of Oligorecurrence of Stage I Lung Adenocarcinoma 19 Years After Operation  Dai Sonoda, MD, Masashi Mikubo, MD, Kazu Shiomi, MD, PhD,
Transformation to SCLC after Treatment with the ALK Inhibitor Alectinib  Shiro Fujita, MD, PhD, Katsuhiro Masago, MD, PhD, Nobuyuki Katakami, MD, PhD,
New IASLC/ATS/ERS Classification and Invasive Tumor Size are Predictive of Disease Recurrence in Stage I Lung Adenocarcinoma  Naoki Yanagawa, MD, PhD,
A Hole in the Heart Journal of Thoracic Oncology
Primary Malignant Pericardial Mesothelioma Mimicking Pericardial Metastasis from Adenocarcinoma  Masafumi Horie, MD, Satoshi Noguchi, MD, Wakae Tanaka,
A Different Method in Diagnosis of Multiple Primary Lung Cancer
Prognostic Impact of Node Involvement Pattern in Pulmonary pN1 Squamous Cell Carcinoma Patients  Masayuki Nakao, MD, Junji Yoshida, MD, PhD, Genichiro.
ALK Translocation in Non-small Cell Lung Cancer with Adenocarcinoma and Squamous Cell Carcinoma Markers  Samuel J. Klempner, MD, David W. Cohen, MD, Daniel.
The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs  Patrick Micke,
Aglaya G. Iyevleva, MD, PhD  Journal of Thoracic Oncology 
Osimertinib for Epidermal Growth Factor Receptor Mutation–Positive Lung Adenocarcinoma That Transformed to T790M-Positive Squamous Cell Carcinoma  Naoyuki.
Mirror Mirror on the Wall, Who Is the Fairest of Them All
Carlie S. Sigel, MD, Andre L. Moreira, MD, PhD, William D
Nivolumab-Induced Granulomatous Inflammation of the Pleura
A Rare Subglottic Capillary Hemangioma
Primary Lung Cancer Presenting with Gastrointestinal Tract Involvement: Clinicopathologic and Immunohistochemical Features in a Series of 18 Consecutive.
Atypical Primary Epithelioid Hemangioendothelioma of the Heart
Fetal Adenocarcinoma of the Lung in a 25-Year-Old Woman
Anu Dham, MD, Alexander M. Truskinovsky, MD, Arkadiusz Z
A Rare Case of Endobronchial Amelanotic Melanoma
T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)
Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases  Kanji Nagai, MD, Yasunori Sohara, MD, Ryosuke Tsuchiya, MD,
A Nonresponding Small Cell Lung Carcinoma
Biclonal Non-small Cell Lung Cancer in Disseminated Tumor Cells and Tissue  Anna Puggina, MSc, Verena Kümmerlen, MD, Korinna Jöhrens-Leder, MD, Ulrich.
Genetic Changes in Squamous Cell Lung Cancer: A Review
Dan J. Raz, MD, Jason A. Zell, DO, MPH, Anthony N
EGFR Mutations in Squamous Cell Lung Cancer in Never-Smokers
Joseph G. Parambil, MD, Gregory L. Aughenbaugh, MD, Telma C
Journal of Thoracic Oncology
Quiz Page January 2010 American Journal of Kidney Diseases
David Garfield, MD  Journal of Thoracic Oncology 
Successful Treatment with Pemetrexed in a Patient with Mucinous Bronchioloalveolar Carcinoma: Long-Term Response Duration with Mild Toxicity  Chiyuki.
A B3 Type-Thymoma in a 7-Year-Old Child with Myasthenia Gravis
A Review of First-Line Treatment for Small-cell Lung Cancer
A Small Alveolar Adenoma Resected by Thoracoscopic Surgery
Presentation transcript:

Pulmonary Blastoma with Renal Metastasis Responds to Sorafenib Keerthi Mulamalla, MD, Alexander M. Truskinovsky, MD, Arkadiusz Z. Dudek, MD, PhD  Journal of Thoracic Oncology  Volume 2, Issue 4, Pages 344-347 (April 2007) DOI: 10.1097/01.JTO.0000263719.76944.0a Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Pulmonary blastoma metastasis to the kidney (4.2 × 4.5 cm) before treatment with sorafenib (January 2006). Journal of Thoracic Oncology 2007 2, 344-347DOI: (10.1097/01.JTO.0000263719.76944.0a) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Pulmonary blastoma metastasis to the kidney (2.0 × 3.5 cm) after 2 months of treatment with sorafenib (March 2006). Journal of Thoracic Oncology 2007 2, 344-347DOI: (10.1097/01.JTO.0000263719.76944.0a) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 3 Mesenchymal component of the pulmonary blastoma in the chest wall, resected in May 2004, showing frequent apoptotic bodies (black arrows), solid sheets of small cells with scant cytoplasm, and round to slightly elongated nuclei with clumped chromatin and small nucleoli. Hematoxylin and eosin staining; original magnification ×400. Journal of Thoracic Oncology 2007 2, 344-347DOI: (10.1097/01.JTO.0000263719.76944.0a) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 4 Fetal adenocarcinoma component of the pulmonary blastoma in the chest wall resected in May 2004, with glands lined by pseudostratified columnar epithelium with sub- and supranuclear vacuoles. Hematoxylin and eosin staining; original magnification ×400. Journal of Thoracic Oncology 2007 2, 344-347DOI: (10.1097/01.JTO.0000263719.76944.0a) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 5 Fetal adenocarcinoma component of the pulmonary blastoma in the chest wall resected in May 2004, showing diffuse positive nuclear immunostaining for TTF-1, a pulmonary marker. Hematoxylin and eosin staining; original magnification ×100. Journal of Thoracic Oncology 2007 2, 344-347DOI: (10.1097/01.JTO.0000263719.76944.0a) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 6 Metastatic pulmonary blastoma in the right kidney resected in April 2006 with morphological correspondence to the fetal adenocarcinoma from the chest wall (lower half of field) and squamous differentiation (upper half of field) but no embryonic mesenchyme component. Hematoxylin and eosin staining; original magnification ×400. Journal of Thoracic Oncology 2007 2, 344-347DOI: (10.1097/01.JTO.0000263719.76944.0a) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions